JOHANNA TANIGUCHI: Open Payments
NPI 1770936676 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 33 payments from 13 companies in 2025. Trend: 2023 $341 · 2024 $961 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $280 |
| GENZYME CORPORATION | 2 | $148 |
| PFIZER INC. | 6 | $112 |
| Phathom Pharmaceuticals, Inc. | 6 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $73 |
| Janssen Biotech, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $21 |
Products named: SKYRIZI, DUPIXENT, VOQUEZNA, ENTYVIO, XELJANZ, XIFAXAN, VELSIPITY, CREON.
Industry payments across WA — which companies pay providers there.
